Moxetumomab Pasudotox-tdfk and Omalizumab
Determining the interaction of Moxetumomab Pasudotox-tdfk and Omalizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Omalizumab Subcutaneous
- Moxetumomab Pasudotox-tdfk-Ombitasvir, Paritaprevir, and Ritonavir
- Moxetumomab Pasudotox-tdfk-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Moxetumomab Pasudotox-tdfk-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Moxetumomab Pasudotox-tdfk-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Moxetumomab Pasudotox-tdfk-Omeclamox-Pak
- Omalizumab-Moxetumomab pasudotox-tdfk Intravenous
- Omalizumab-Moxifloxacin
- Omalizumab-Moxifloxacin (Systemic)
- Omalizumab-Moxifloxacin Hydrochloride
- Omalizumab-Moxifloxacin Injection
- Omalizumab-Moxifloxacin Intravenous